Carlo Mannina, MD1,2; Kazato Ito, MD1; Zhezhen Jin, PhD3; Yuriko Yoshida, MD1; Kenji Matsumoto, MD1; Sofia Shames, MD1; Cesare Russo, MD1,4; Mitchell S. V. Elkind, MS, MD5,6; Tatjana Rundek, MS, MD, PhD7,8,9; Mitsuhiro Yoshita, MD10; Charles DeCarli, MD11; Clinton B. Wright, MD12; Shunichi Homma, MD1; Ralph L. Sacco, MS, MD7,8,9; Marco R. Di Tullio, MD1,13
doi : 10.1001/jamacardio.2022.5449
April 2023, Vol 8, No. 4, Pages 305-408
Importance The risk of ischemic stroke is higher among patients with left atrial (LA) enlargement. Left atrial strain (LAε) and LA strain rate (LASR) may indicate LA dysfunction when LA volumes are still normal. The association of LAε with incident ischemic stroke in the general population is not well established.
Søren Zöga Diederichsen, MD, PhD1; Lucas Yixi Xing, MD1; Diana My Frodi, MD1; Emilie Katrine Kongebro, MD1; Ketil Jørgen Haugan, MD, PhD2; Claus Graff, PhD3; Søren Højberg, MD, PhD4; Derk Krieger, MD, PhD5; Axel Brandes, MD, DMSc6,7,8; Lars Køber, MD, DMSc1,9; Jesper Hastrup Svendsen, MD, DMSc1,9
doi : 10.1001/jamacardio.2022.5526
Importance There is increasing interest in heart rhythm monitoring and technologies to detect subclinical atrial fibrillation (AF), which may lead to incidental diagnosis of bradyarrhythmias.
Billy A. Caceres, PhD, RN1; Yashika Sharma, MPhil, MSN, RN1; Rohith Ravindranath, BS1; Ipek Ensari, PhD2; Nicole Rosendale, MD3; Danny Doan, MPH1; Carl G. Streed, MD, MPH4,5
doi : 10.1001/jamacardio.2022.5660
Importance Research on the cardiovascular health (CVH) of sexual minority adults has primarily examined differences in the prevalence of individual CVH metrics rather than comprehensive measures, which has limited development of behavioral interventions.
Nicklaus P. Ashburn, MD, MS1,2; Anna C. Snavely, PhD1,3; James C. O’Neill, MD1; Brandon R. Allen, MD4; Robert H. Christenson, PhD5; Troy Madsen, MD6; Michael R. Massoomi, MD7; James K. McCord, MD8; Bryn E. Mumma, MD, MAS9; Richard Nowak, MD10; Jason P. Stopyra, MD, MS1; Maite Huis in’t Veld, MD11; R. Gentry Wilkerson, MD11; Simon A. Mahler, MD, MS1,12,13
doi : 10.1001/jamacardio.2023.0031
Importance The European Society of Cardiology (ESC) 0/1-hour algorithm is a validated high-sensitivity cardiac troponin (hs-cTn) protocol for emergency department patients with possible acute coronary syndrome. However, limited data exist regarding its performance in patients with known coronary artery disease (CAD; prior myocardial infarction [MI], coronary revascularization, or ≥70% coronary stenosis).
Leo F. Buckley, PharmD1; Insa M. Schmidt, MD, MPH2; Ashish Verma, MD2; Ragnar Palsson, MD3; Debbie Adam, BS4; Amil M. Shah, MD, MPH5; Anand Srivastava, MD, MPH6; Sushrut S. Waikar, MD, MPH2
doi : 10.1001/jamacardio.2023.0056
Importance Histologic lesions in the kidney may reflect or contribute to systemic processes that may lead to adverse cardiovascular events.
Mark Ledwidge, PhD1,2; Jonathan D. Dodd, MD2,3; Fiona Ryan, PhD1; Claire Sweeney, PhD1; Katherine McDonald, MB1; Rebecca Fox, BSc1; Elizabeth Shorten, BSc1; Shuaiwei Zhou, PhD1; Chris Watson, PhD1,2,4; Joseph Gallagher, MD2; Niall McVeigh, MD2,3; David J. Murphy, MD2,3; Kenneth McDonald, MD1,2
doi : 10.1001/jamacardio.2023.0065
Importance Pre–heart failure with preserved ejection fraction (pre-HFpEF) is common and has no specific therapy aside from cardiovascular risk factor management.
Jacob B. Pierce, MD, MPH1; Uchechukwu Ikeaba, MS2; Anthony E. Peters, MD2,3; Adam D. DeVore, MD, MHS2,3; Karen Chiswell, PhD2; Larry A. Allen, MD, MHS4; Nancy M. Albert, PhD5; Clyde W. Yancy, MD, MSc6,7; Gregg C. Fonarow, MD8,9; Stephen J. Greene, MD2,3
doi : 10.1001/jamacardio.2023.0241
Importance Prior studies have suggested patients with heart failure (HF) from rural areas have worse clinical outcomes. Contemporary differences between rural and urban hospitals in quality of care and clinical outcomes for patients hospitalized for HF remain poorly understood.
Jawad H. Butt, MD1,2; Kieran F. Docherty, MBChB, PhD1; Brian L. Claggett, PhD3; Akshay S. Desai, MD, MPH3; Magnus Petersson, MD, PhD4; Anna Maria Langkilde, MD, PhD4; Rudolf A. de Boer, MD, PhD5; Adrian F. Hernandez, MD6; Silvio E. Inzucchi, MD7; Mikhail N. Kosiborod, MD8; Lars Køber, MD, DMSc2; Carolyn S. P. Lam, MD9; Felipe A. Martinez, MD10; Piotr Ponikowski, MD, PhD11; Marc S. Sabatine, MD, MPH12; Sanjiv J. Shah, MD13; Muthiah Vaduganathan, MD, MPH3; Pardeep S. Jhund, MBChB, MSc, PhD1; Scott D. Solomon, MD3; John J. V. McMurray, MD1
doi : 10.1001/jamacardio.2022.5608
Importance Gout is common in patients with heart failure (HF), and sodium-glucose cotransporter 2 inhibitors, a foundational treatment for HF, reduce uric acid levels.
Jonathan Golledge, MChir1,2,3; Lisan Yip, MSc1; Alkira Venn, BExPHys(Clin)1; Anthony S. Leicht, PhD3,4; Jason S. Jenkins, MBBS5; Maria A. Fiatarone Singh, PhD6,7; Christopher M. Reid, PhD8,9; Zanfina Ademi, PhD9,10; Belinda J. Parmenter, PhD11; Joseph V. Moxon, PhD1,3; Nicola W. Burton, PhD12,13,14; for the BIP Investigators
doi : 10.1001/jamacardio.2022.5437
Importance It is unclear how to effectively promote walking in people with peripheral artery disease (PAD).
Anum S. Minhas, MD, MHS1,2; Justin B. Echouffo-Tcheugui, MD, PhD3; Sui Zhang, MS4; Chiadi E. Ndumele, MD, PhD, MHS1,2,4; J. William McEvoy, MB, BCH, MHS, PhD2,5; Robert Christenson, PhD6; Elizabeth Selvin, PhD, MPH4
Daniel B. Kramer, MD, MPH1,2; Marie E. G. Moe, PhD3; Nicholas S. Peters, MD4,5
Mary M. McDermott, MD1
Mark H. Schoenfeld, MD1; Kristen K. Patton, MD2,3
Júlia Karády, MD1,2; David A. Morrow, MD, MPH3
Cody McCoy, MD1; John M. Miller, MD1; Tanyanan Tanawuttiwat, MD, MPH1
Praveen Gupta, DM1
Elnur Tahirović, MD, PhD1,2; Nermir Granov, MD, PhD1
Vishal K. Narang, MD1; Matthew Budoff, MD, MSSCT2
Do you want to add Medilib to your home screen?